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OBJECTIVES The goal of this study was to assess the influence of collateral function, coronary
hemodynamics, and the angiographic result on the risk of target vessel failure (TVF) after
recanalization of a chronic total coronary occlusion (CTO).
BACKGROUND Collaterals may have an adverse effect on TVF.
METHODS In 111 consecutive patients, a CTO (duration 2 weeks) was successfully recanalized with
stent implantation. Collateral function was assessed by intracoronary Doppler flow velocity
and pressure recordings distal to the occlusion. Baseline collateral function was determined
before the first balloon inflation, and recruitable collateral function after stenting during a
balloon reocclusion. Finally, the coronary flow velocity reserve (CFVR) and the fractional
flow reserve (FFR) were measured.
RESULTS Angiographic follow-up after 5  1.4 months in 106 patients showed a reocclusion in 17%
and a restenosis in 36%. The major determinants of TVF were the stent length (p  0.01)
and number of implanted stents (p  0.01). No difference was observed in baseline or
recruitable collateral function between patients with and without TVF; 52% of patients had
a CFVR 2.0, and only 18% a CFVR 2.5 after percutaneous transluminal coronary
angioplasty, but neither cutoff-value predicted TVF. A low FFR discriminated patients with
reocclusion (0.81  0.07 vs. 0.86  0.08, p  0.05) but not with restenosis (0.87  0.06).
CONCLUSIONS This study showed that there is no relation between a well-developed collateral supply and the
risk of TVF in recanalized CTOs. This was rather determined by the stented segment length.
There was also no adverse effect of the frequently observed impaired CFVR on TVF, whereas
a low FFR was associated with a higher risk of reocclusion. (J Am Coll Cardiol 2003;42:
219–25) © 2003 by the American College of Cardiology Foundation
The rationale for recanalizing a chronic total coronary
occlusion (CTO) is to relieve symptoms of angina and
improve impaired left ventricular (LV) function (1–3) with
a favorable effect on survival (4). However, the angioplasty
of CTOs is hampered by a higher recurrence rate than in
nonocclusive lesions (5,6), especially a higher rate of reoc-
clusion, which is uncommon in nonocclusive lesions (7).
The routine use of coronary stents in CTOs reduces but
does not abolish these specific features of lesion recurrence
(8–11). Possible explanations for this high recurrence rate
could be the specific morphology of occluded lesions (12–
16), the presence of a concurrent flow via residual collaterals
after recanalization (17–20), or the impairment of coronary
flow by a high prevalence of microvascular dysfunction
(21,22).
The relevance of procedural parameters such as stent
length and the angiographic result had been shown to be
major determinants of target vessel failure (TVF) in CTOs
(23). However, the potential influence of collateral and
coronary hemodynamics had not been assessed previously.
This can be done through the application of microsensor
wires to assess intracoronary flow and pressure before and
during percutaneous transluminal coronary angioplasty
(PTCA) (24). The present study should test the hypothesis
of a possible confounding effect of collateral function and
coronary hemodynamics on restenosis and reocclusion in a
nonselected, prospective consecutive series of successfully
recanalized CTOs.
METHODS
Patients. All consecutive CTOs of a major coronary
branch (diameter 2.5 mm) scheduled for PTCA between
January 1999 and April 2002 at the University Hospital at
Jena, Germany, were included in this study if the duration
of the occlusion was 2 weeks and if there were spontane-
ously visible collaterals. The duration of CTOs was 0.5 to
337 months (median 4 months). The indication for PTCA
was either chest pain related to the CTO or persistent
occlusion after a prior myocardial infarction (MI). Of 138
CTOs, 117 were successfully recanalized, and 111 could be
studied according to the study protocol described below.
Angiographic follow-up was available in 106 patients, who
constitute the study group. The study was approved by the
university’s ethics committee, and written informed consent
obtained.
Angioplasty procedure. The recanalization was done as
previously described (25). All patients were being treated
with aspirin (100 mg) and received clopidogrel (75 mg) for
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four weeks starting on the day of the procedure. After the
lesion was crossed by a guidewire, an exchange catheter
(Transit, Cordis, Miami, Florida) or a low profile over-the-
wire balloon catheter (Bandit, Scimed, Boston Scientific
Corporation, Natick, Massachusetts) was advanced distal to
the occlusion. Then the guidewire was exchanged for a
0.014-inch Doppler guidewire (FloWire, Endosonics/
Jomed, Rancho Cordova, California) to record Doppler
flow velocity distal to the occlusion. Then the Doppler wire
was exchanged for a 0.014-inch pressure wire (Pres-
sureWire, RADI Medical Systems AB, Uppsala, Sweden)
to record coronary pressure distal to the occlusion (POccl).
After the Doppler and pressure recordings, the occlusion
was dilated and treated by stent implantation. The stent
expansion was optimized according to angiographic criteria
with a balloon-to-artery ratio of at least 1.1.
Protocol for intracoronary Doppler and pressure record-
ings of collateral flow. The angiographic anatomy distal to
the occlusion was visualized by a contrast injection through
the exchange catheter to aid the positioning of the sensor
wires. The Doppler wire was advanced 1 to 2 cm distal to
the occlusion in a segment without a focal stenosis to a
position where a clearly defined and stable velocity signal
could be recorded. These Doppler recordings of baseline
collateral flow were done before the first balloon inflation.
The absence of antegrade flow was ascertained by lack of
distal opacification after proximal contrast injection and no
interference with the distal Doppler signal. All Doppler
flow signals were measured manually as described before
(25,26). Depending on the relative position of the Doppler
wire to the collateral inflow, the detected flow could be
antegrade, retrograde, or bidirectional, and, therefore, the
absolute values were used for further computation of the
average peak velocity (APV).
For the pressure recording, care was taken to position the
transducer at the same spot where the Doppler wire tip had
been located. The mean pressure of POccl and the aortic
pressure (PAo), which was obtained through the fluid filled
6F or 7F guiding catheter, were used for further computa-
tion. A collateral pressure index (CPI) was calculated (27).
The formula includes the central venous pressure (CVP):
CPI  (POccl  CVP)/(PAo  CVP). In most patients
CVP was not measured directly and substituted in the
formula by 10 mm Hg. This was based on 24 patients with
invasive measurement of CVP of 10 3 mmHg, which did
not change significantly during balloon reocclusion.
In 85 patients, recruitable collateral function was reas-
sessed at the end of the PTCA during a balloon inflation,
with the last balloon used for the stent expansion. The
identical location of the Doppler wire for all recordings was
ascertained by fluoroscopy on two orthogonal planes with
only minimal variations allowed to optimize the Doppler
signal. Likewise, the pressure recording was repeated during
a balloon reocclusion.
Functional assessment by Doppler and pressure record-
ings after recanalization. After the PTCA, the Doppler
wire was positioned distal to the stented site with a distance
to side branches of at least 5 mm. At this position the
antegrade APV was recorded. When the Doppler signal was
stable, 20 to 40 g of adenosine were injected rapidly,
intracoronary, and the maximum increase of flow velocity
was recorded to calculate the coronary flow velocity reserve
(CFVR) as the ratio of hyperemic and baseline antegrade
APV. The adenosine injection was repeated three times and
averaged for further analysis.
Finally, the pressure wire was used to calculate the
fractional flow reserve (FFR) at the end of the PTCA (28).
The wire was positioned about 1 cm distal to the stented
lesion. Intracoronary distal pressure (PD) and PAo were
recorded on an identical scale at a speed of 10 mm/s.
Particular care was taken to avoid artifacts by the guiding
catheter, the pressure transducer position, and the selective
intracoronary injection of 20 to 40 g of adenosine (29). A
simplified formula for myocardial FFR  PD/PAo was used
(30). The measurement of FFR was repeated three times
and averaged for further analysis.
Quantitative coronary angiography. The collateral supply
was graded according to Rentrop et al. (31). Pre-
interventional angiograms showed either collateral flow
grade 2 (partial epicardial filling of the occluded artery) or 3
(complete epicardial filling of the occluded artery). The LV
function at baseline and at follow-up was analyzed using a
standard software program (LVA 4.0, PieMedical Imaging,
Maastricht, the Netherlands). The centerline method was
used to assess regional LV function in the territory of the
recanalized artery by the regional wall motion severity index
(SD/chord) (32).
The final result of stent implantation (reference diameter,
minimum lumen diameter [MLD], residual stenosis, and
lesion length) was assessed by quantitative angiography
using the smallest diameter from two orthogonal planes
(QCA 4.0, PieMedical Imaging, Maastricht, the Nether-
lands). Quantitative angiography was repeated at follow-up,
and a restenosis was defined as an MLD in the recanalized
artery of 50% of the reference diameter.
Abbreviations and Acronyms
APV  average peak velocity
CFVR  coronary flow velocity reserve
CPI  collateral pressure index
CTO  chronic total coronary occlusion
CVP  central venous pressure
FFR  fractional flow reserve
LV  left ventricular
MI  myocardial infarction
MLD  minimum lumen diameter
PAo  mean aortic pressure
PD  mean pressure distal to the lesion
POccl  mean pressure distal to the occlusion
PTCA  percutaneous transluminal coronary angioplasty
TVF  target vessel failure
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Statistics. Data are given as the mean value  SD if not
indicated otherwise. Group differences of continuous vari-
ables were evaluated by analysis of variance (ANOVA) and,
in case of a significant result followed, by an LSD post-hoc
test. Group differences of categorical variables were tested
by a chi-squared test. A paired t test was used to compare
changes of LV function during follow-up. A logistic regres-
sion analysis was done to assess determinants of TVF. A
level of p 0.05 was considered significant. All calculations
were done with SPSS for Windows (Version 10.05, SPSS
Inc., Chicago, Illinois).
RESULTS
Clinical follow-up. Of 111 patients entered in this study,
two patients died suddenly one and three weeks after PTCA
with open stents confirmed by autopsy; one patient had a
subacute stent thrombosis; and two patients without clinical
symptoms of recurrent angina declined a repeat angiogra-
phy. Repeat angiography after 5.0  1.4 months in the
remaining 106 patients showed a reocclusion in 17.0% and
a restenosis in 35.8%. The TVF was 52.8%. Target lesion
revascularization was 50.9% with repeat PTCA in 43.4%
and bypass surgery in 7.5%. Clinical symptoms of angina
and heart failure were improved in 78%, unchanged in 15%,
and deteriorated in 7%—the latter in patients with reocclu-
sion at follow-up. There were no differences in clinical
baseline parameters among patients with and without TVF
(Table 1).
Quantitative angiography and TVF. Of the angiographic
parameters, the reference diameter and the MLD were
similar in patients with and without TVF (Table 1), but
there was a significantly higher number of stents and a
longer stented segment in patients with restenosis and
reocclusion (Fig. 1). In 43 patients with only one stent, the
TVF was 34.9% with 11.6% reocclusions, whereas, with2
stents, the TVF increased to 71.4% with 19% reocclusion
(Fig. 2).
Collateral function and TVF. Both Doppler and pressure
parameters of collateral function measured before recanali-
zation were similar in patients with and without TVF
(Table 2). The parameters of recruitable collateral function
assessed 47  13 min after the baseline measurement
showed also no significant difference in Doppler and pres-
sure recordings. The distribution of CPI with and without
TVF is shown in Figure 3.
Coronary hemodynamics and TVF. After recanalization,
the CFVR did not differ between patients with and without
TVF (Table 2). An impaired CFVR 2.0 after PTCA was
observed in 48%. Both a CFVR 2.0 and an FFR 0.75
Table 1. Comparison of Patients With CTOs With and Without TVF
No TVF
n  50
Restenosis
n  38
Reocclusion
n  18 p Value
Age (yrs) 63.6  9.0 62.4  11.5 65.1  9.5 0.63
Male gender (%) 74 76 67 0.74
Number of diseased arteries (1/2/3) (%) 40/42/18 37/45/18 39/44/17 1.0
Duration of occlusion (3 months) (%) 56 42 67 0.19
Previous myocardial infarction (%) 66 68 56 0.64
CCS (1/2/3/4) (%) 2/40/56/2 5/34/61/0 4/40/56/0 0.78
NYHA (0/1/2/3/4) (%) 0/38/46/16/0 5/40/42/13/0 0/50/28/22/0 0.45
Diabetes (%) 30 37 50 0.32
Hypertension (%) 68 76 67 0.65
Hypercholesterolemia (%) 68 84 78 0.21
History of smoking (%) 44 47 39 0.84
Ejection fraction (%) 55.8  19.2 58.7  17.3 61.8  18.8 0.48
Wall motion severity index (SD/chords) 1.96  1.44 2.00  1.24 1.82  1.19 0.89
Reference diameter (mm) 2.74  0.56 2.73  0.55 2.62  0.37 0.70
MLD (mm) 2.29  0.58 2.21  0.45 2.08  0.44 0.32
Diameter stenosis (%) 17  10 18  12 21  10 0.39
Number of stents 1.6  0.9 2.1  0.9 2.2  1.2 0.009
Stent length (mm) 20.0  10.4 29.1  17.2 26.4  11.4 0.006
Data are mean (SD) or number (%).
CCS  Canadian Cardiovascular Society; CTO  chronic total coronary occlusion; LAD  left anterior descending; LCX  left circumflex; MLD  minimum luminal
diameter; NYHA  New York Heart Association; TVF  target vessel failure.
Figure 1. Difference in stent length among patients with and without
target vessel failure (TVF) after recanalization of a chronic total coronary
occlusion. Individual data points and mean  SD are shown. The p values
represent the post-hoc analysis of the analysis of variance (p  0.006).
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was observed in 44%, indicating the presence of microvas-
cular disease. Both a reduced CVR and FFR was observed
in 4% as evidence of diffuse atherosclerosis. Patients with
microvascular disease had a TVF of 47%, which was even
slightly but insignificantly lower than the TVF of 58% in
patients with a CFR 2.0 and an FFR 0.75 (p  0.51).
A high CFVR2.5 was observed in only 18% of patients
with a TVF of 56%, which was similar to the TVF of 51%
in patients with a CFVR 2.5 (p  0.93). There was also
no difference in CFVR with respect to patients with
reocclusion. In contrast, the FFR was significantly lower in
patients with a reocclusion, but there was no difference
between patients with and without restenosis (Fig. 4). An
FFR 0.9 was observed in 41% of patients. These patients
had a similar TVF of 55.6% but a lower reocclusion rate
(5.6%) than patients with an FFR 0.9, a TVF of 53.8%,
but a reocclusion rate of 21.2%. An FFR 0.95 was
achieved in only 12.5% of patients, none of whom had a
reocclusion, with a TVF of 36%, compared with 53% in
patients with an FFR 0.95 (p  0.25).
Predictors of TVF. In a logistic regression analysis to
determine predictors of TVF, we included quantitative
angiographic parameters (stented segment length, stent
number, reference diameter, and MLD), collateral function
Figure 2. The difference in recurrence rate after recanalization of chronic
total coronary occlusions depending on the number of implanted stents.
The relative distribution is shown; the numbers indicate the absolute
number of patients. Chi-squared test for the difference between groups: p
 0.037. TVF target vessel failure.
Table 2. Collateral and Coronary Hemodynamic Assessment in Patients With CTOs
No TVF
n  50
Restenosis
n  38
Reocclusion
n  18 p Value
Rentrop grade 3 (%) 76 79 77 0.94
APVOccl baseline (cm/s) 10.4  5.7 10.7  5.4 10.7  7.1 0.98
APVOccl recruitable (cm/s) 5.8  3.4 7.1  4.2 7.3  6.4 0.32
POccl baseline (mm Hg) 45  15 44  15 47  13 0.78
POccl recruitable (mmHg) 35  13 36  15 36  13 0.97
CPI baseline 0.39  0.13 0.41  0.11 0.41  0.10 0.62
CPI recruitable 0.29  0.12 0.32  0.14 0.32  0.12 0.60
Baseline APV (cm/s) 31.4  16.5 27.8  12.6 31.3  17.3 0.54
Hyperemic APV (cm/s) 57.1  28.0 54.5  21.1 62.6  34.7 0.61
CFVR 1.95  0.61 2.07  0.52 2.06  0.59 0.59
FFR 0.86  0.08 0.87  0.06 0.81  0.07 0.027
Data are mean  SD or (%).
APV  average peak velocity; APVOccl  average peak velocity distal to occlusion; CFVR  coronary flow velocity reserve; CPI  collateral pressure index; CTO  chronic
total coronary occlusion; FFR  fractional flow reserve; POccl  mean coronary pressure distal to occlusion; TVF  target vessel failure.
Figure 3. Collateral pressure index before (baseline) (A) and after (re-
cruitable) (B) recanalization of a chronic total coronary occlusion with no
significant difference between groups. Individual data points and mean 
SD. ANOVA  analysis of variance; TVF  target vessel failure.
222 Werner et al. JACC Vol. 42, No. 2, 2003
Collaterals and TVF in Chronic Occlusions July 16, 2003:219–25
parameters, CFVR, and FFR. None of the functional
parameters had a significant influence on TVF. The stented
segment length remained the best predictor (p  0.007),
followed by the MLD (p  0.015).
Relation between LV function and TVF. The baseline
global and regional LV function was not significantly different
in patients with and without TVF. Despite the high rate of
restenosis, both the LV ejection fraction and regional wall
motion severity index improved similarly in patients with
restenosis and without TVF. However, LV function did not
improve in patients with reocclusion (Fig. 5).
DISCUSSION
The present study is the first to investigate the influence of
directly assessed collateral function and coronary flow re-
serve on the risk of TVF after the recanalization of a CTO.
Neither good collateral function at baseline nor an impaired
coronary flow reserve after PTCA were predictors of TVF.
The major predictor of TVF was the length of the stented
segment. Furthermore, the risk of reocclusion was predicted
by a low FFR after PTCA. The FFR appeared superior to
CFVR in assessing the angioplasty result in CTOs.
TVF in chronic occlusions. This study was done in an
unselected cohort of consecutive patients with a successful
recanalization of a CTO. Despite the routine use of stents,
the TVF was high compared with some of the randomized
studies in CTOs. However, most of these studies had
applied exclusion criteria regarding reference vessel diameter
(2.5 mm), and technical feasibility, which resulted in the
exclusion of more than 50% of the screened patients
(8,9,11,33). One study with less restrictive inclusion criteria
had similar recurrence rates (10). Furthermore, the length of
the lesion was no exclusion criterion, and the number of
stents used was consequently high. Lesions treated with a
single stent had a lower TVF than those treated with
multiple stents and were comparable to the results of the
aforementioned randomized studies (8,9,33).
Collaterals and the risk of TVF. Previous reports sug-
gested that well-preserved collaterals are one of the factors
responsible for the high TVF in CTOs (17,18). This was
explained by an increased distal coronary pressure and
concurrent flow via persistent collaterals in analogy to
observations after bypass surgery of a progress in lesion
severity in the native bypass receiving coronary artery
(34,35). With native collaterals, however, concurrent collat-
eral flow is much lower than that provided by a bypass graft.
Previous studies that suggested an adverse effect of collat-
erals on TVF used the angiographic appearance of collat-
Figure 4. Coronary flow velocity reserve (CFVR) (A) and fractional flow
reserve (FFR) (B) among patients with and without target vessel failure
(TVF) after recanalization of a chronic total coronary occlusion. Individual
data points and mean  SD are shown. The p values represent the analysis
of variance (ANOVA) result for CFVR and the post-hoc analysis of the
ANOVA for FFR (p  0.027).
Figure 5. Global (A) and regional (B) left ventricular (LV) function before
recanalization and at follow-up in patients with and without target vessel
failure (TVF). There were no differences at baseline, with improvement
during follow-up in all patients except those with reocclusion. p values for
paired t test. Open bars  baseline; hatched bars  follow-up.
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erals as a criterion of collateral function, and they compared
nonocclusive and occlusive lesions (17,18). There is no
doubt that CTOs have a better collateral supply, which may
serve as an explanation for the high TVF rate, but there are
also considerable differences in the morphology of a CTO
lesion with higher plaque load than a nonocclusive lesion,
which may influence the risk of TVF (13–15).
Therefore, we looked exclusively at CTOs with a wide
variability of collateral supply to study the influence of
concurrent flow via collaterals on the risk of restenosis and
reocclusion as demonstrated by the invasive assessment of
collateral flow and pressure. We assessed both baseline and
recruitable collateral function, the latter being the relevant
source of concurrent flow after recanalization. Despite the
use of a physiologic measure of collateral supply, which is
superior to angiographic methods for the assessment of
collaterals (36,37), we observed no adverse effect of a
well-developed collateral system on TVF in CTOs.
Collateral function after recanalization of CTOs.
Collateral function is lost after recanalization of CTOs
(25,26), which becomes clinically evident with an MI rate of
up to 6% within six months after PTCA (8–11). As this rate
is lower than the actual incidence of reocclusion, either
some CTOs remain protected from ischemic events by a
residual collateral function (38) or collaterals recover during
a gradual reocclusion. In our study the high rate of reocclu-
sion was not associated with MI, but with recurrence of
clinical symptoms in half of the patients with reocclusion.
This is indirect evidence that the reocclusion occurred
gradually and allowed for recruitment of collaterals sufficient
to prevent an MI (39).
Coronary flow reserve and FFR and the risk of TVF. In
nonocclusive lesions an impaired CFVR after PTCA iden-
tified patients with a high TVF and adverse event rate
during long-term follow-up, but it was unclear whether it
was of similar relevance in CTOs (22,40). The incidence of
microembolization during PTCA is a potential cause for
this observation (41). However, we could recently demon-
strate that the incidence of troponin and creatinine kinase
increase after recanalization of a CTO was 10% and did
not account for the impaired CFVR in almost half of all
patients (42). The impaired CFRV was not associated with
a higher risk of TVF in CTOs. Thus, criteria based on
CVFR for the guidance of balloon angioplasty for nonoc-
clusive lesions are not applicable to CTOs with routine
stenting (22).
In contrast, the recording of the FFR provided informa-
tion that could be relevant for the PTCA. A low FFR after
recanalization was associated with a high risk of reocclusion.
As a reocclusion impedes LV recovery, every effort should
be made to reduce its incidence, and FFR might be a
valuable tool for this purpose. In a recently reported large
registry of nonocclusive lesions, an FFR 0.90 predicted a
low incidence of major adverse cardiac events (43). In CTOs
we achieved an FFR0.90 in only 41% of patients, with no
difference in TVF. However, an FFR 0.95 in 12.5% of
patients tended to be associated with a lower TVF. Even
though this was not a significant effect, it may indicate that
a more “aggressive optimization” guided by FFR should be
tried to further improve the outcome. Whether this is a
feasible approach, given the often diffuse atherosclerosis of
the occluded artery, remains to be proven by a future study.
Study limitations. Studies in CTOs often contain a lim-
ited number of patients because CTOs constitute 10% of
all patients undergoing a PTCA and the primary success
rate is about 70%. The present study represents a large
single-center series of CTOs with the additional strength of
a prospective and consecutive patient inclusion and a sole
exclusion criteria of a reference diameter 2.5 mm. Despite
the limited number of patients, the high percentage of TVF
provides a statistical power for a meaningful analysis.
Limitations of the invasive assessment of collateral func-
tion in CTOs by Doppler and pressure wires had been
discussed in detail before (25,26). In principal, vascular flow
is assessed by Doppler velocimetry, not by volume flow
measurement. Specific care was taken for exact positioning
of the pressure and Doppler wire under fluoroscopic control
using angiographic landmarks. Furthermore, the CPI,
which as a pressure-derived index is less sensitive to the
exact wire tip position, also showed no difference between
patients with and without TVF, further corroborating the
Doppler findings.
Clinical implications. The presence of well-developed col-
laterals and the high prevalence of a low CFVR after PTCA
does not influence the risk of lesion recurrence after recan-
alization of CTOs and should not prevent us from attempt-
ing a recanalization. The improvement of LV function can
be considerable despite the frequent incidence of restenosis,
which might be targeted successfully by drug-eluting stents
(44). Still, the incidence of reocclusion is a specific problem
of CTOs that impedes LV recovery. Target vessel failure
may be reduced by limiting the number of stents, and FFR
might be useful for the guidance of the angioplasty to avoid
reocclusions. Such an FFR-guided approach with the goal
of limiting the number of stents should be tested
prospectively.
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